False Claims Act

Latest Headlines

Latest Headlines

Sanofi settles Hyalgan kickback probe for $109M

Amgen's $762 million marketing settlement has grabbed the biggest headlines, but Sanofi also announced a False Claims Act deal. The French drugmaker agreed to pay $109 million to wrap up a Justice Department probe into kickback allegations. The case didn't involve criminal charges.

Whistleblowers: Merck hid declining efficacy of MMR shot

Two former Merck ($MRK) employees lodged a whistleblower suit against the drugmaker, alleging that it overstated the effectiveness of its MMR vaccine.

$1B Risperdal marketing suit hits Texas court

As Johnson & Johnson ($JNJ) negotiates its Risperdal marketing settlement with the feds, it's going to court in Texas today to fight $1 billion in potential damages. The whistleblower lawsuit,

Pharma fraud fills feds' coffers

The Justice Department says it secured more than $3 billion in settlements and judgments in civil cases involving fraud against the government in the fiscal year that ended Sept. 30--and the bulk of

Genentech to pay $20M in Rituxan whistleblower suit

Genentech joins the whistleblower-settlement crowd, albeit with a payment dwarfed by most of the pharma industry's False Claims Act deals. As the San Francisco Business Times reports, the Roche unit

Watson, Sandoz settle Medicaid whistleblower suits for $145M

Watson Pharmaceuticals ($WPI) and Novartis' ($NVS) generics unit Sandoz have agreed to settle False Claims Act lawsuits alleging they overstated the prices on drugs sold to Medicaid programs. Watson

Par used Medicaid rule to overcharge for meds, suit says

Par Pharmaceutical ($PRX) exploited a loophole in Medicaid pricing rules to boost its sales--and overcharge the federally funded program at the same time, a whistleblower suit claims. The U.S.

Would capped payments deter pharma whistleblowers?

Are whistleblowers paid too much? A former U.S. attorney thinks so. Michael Loucks, a former prosecutor in Boston, is advocating for a cap of $2 million, the Wall Street Journal reports. That's far

Justice sues Boston Sci over faulty defibrillators

The Justice Department is suing Boston Scientific and its Guidant unit under the False Claims Act for conduct related to the faulty heart devices Ventak Prizm 2 and the Renewal 1 and 2. The

FDA fraud-busting pilot program aims at pharma

Earlier this week, HHS trumpeted its efforts to root out healthcare fraud and recover $4 billion for taxpayers, including about $2.5 billion attributed to violations of the False Claims Act, which